Cambridge Healthtech Institute’s Tenth Annual
Recombinant Protein Therapeutics
PepTalk: The Protein Science Week
January 13-14, 2014
By combining modular building blocks, Fusion protein therapeutics have an advantage over antibody-based therapies resulting in a customizable functionality. Fusion protein therapeutics can also access several targets on different proteins or on the same protein with the potential to reach targets that are not accessible to antibodies. Additional advantages include lower patient dosing, reduced production costs, and improved product homogeneity. This meeting will explore the varying constructs and ‘designs’ of fusion protein therapeutics, and will discuss how they are being engineered to form more efficacious therapeutics that offer specificity with enhanced stability and longer half life. Experts will present case studies from R&D through clinical data, and will share the results they’ve achieved.
Please join leaders from around the world for this in-depth discussion of the innovations being developed for the next-generation protein-based therapeutics.
We invite presentation proposals on the following preliminary topics:
- Case studies
- Fc engineering
- Cell-killing fusion proteins
- Antibody/domain-based fusions
- Pharmacological activity
- Stability/immunogenicity
- Prolonging half life
- Assays
- Binding
- Delivery
- Cytotoxic effects
- Bifunctional fusion proteins
- Chimeric protein
- Receptor traps
- Preclinical development
- Formulation technologies
Please click here to submit a speaking proposal for review.
Deadline for submission: June 7, 2013
All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
For questions about the meeting, contact:
Mary Ruberry
Conference Director
Cambridge Healthtech Institute
Phone: 781-972-5421
Email: mruberry@healthtech.com
For partnering & sponsorship information, please contact:
Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com
Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com